Loaded with prebiotic fiber which can help feed the good bacteria in your mouth.
Balances the PH of the mouth.
Contains theobromine which has shown significant remineralization in teeth in artificial decay tests
Pain relieving effects from eugenol.
Balances the PH of the mouth, creating an alkaline environment which reduces the acids that create tooth decay.
Can prevent bacteria from producing sulfur gasses.
Removes plaque and biofilm.
Studies have shown CBD can help reduce inflammation.
Studies have shown CBG can help stimulate bone growth.
Promotes healthy bones and teeth.
Promote overall tooth and tissue health.
Promotes healthy bones and teeth.
Helps balance the PH of the oral cavity.
CBD, short for cannabidiol, is a chemical compound from the cannabis plant. It's a naturally occurring substance derived from hemp or cannabis. Unlike its cousin tetrahydrocannabinol (THC), it's non-psychoactive, meaning it does not get you high. CBD is used in a wide variety of edibles, tinctures, vape pens and cosmetics to help with inflammation, siezures, nausea, pain, anxiety, infections and much more.
Studies have shown when CBD is introduced to the ECS, it stops the body from absorbing a pain regulating compound known as anandamide- one of our bodies own natural cannabinoid molecules. Inhibiting the absorption of this compound shunts excess quantities into the bloodstream that in turn reduces pain. CBD has been shown in carious studies to inhibit inflammatory cells from being produces and migrating to the site of injury. This reducing inflammation and pain in that area, CBD has been tested against many firms if bacteria and shown to have antibacterial properties as well.
All cannabinoids, including CBD, produce effects in the body by attaching to certain receptors. CBD directly interacts with the endocannabinoid system and a number of proteins in the body and central nervous system. The endocannabinoid system contains two types of receptors, CB1, which is predominantly expressed in the brain and CB2, which is primarily found on the cells of the immune system. Most cannabinoids can bind to both types of receptors- CB1 & CB2. This is true for both the endocannabinoids – anandamide & 2-AG- and for phytocannabinoids like THC. However, the phytocannabinoid CBD doesn't directly trigger either receptor. Instead, it modifies the receptors ability to bind to cannabinoids.
Cannabigerol is a non-psychoactive cannabinoid, found in small amounts of the plant before maturation. It is found in much larger concentrations in the hemp plant. CBG is the chemical precursor to CBD, THC. And CBC. Cannabis plants produce cannabigerolic acid (CBGA), the precursor to the three main cannabinoid lines: tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA), and cannabichromenic acid (CBCA).
Specific enzymes in the plant break CBGA down and “direct” it toward one of the three lines. The acids are exposed to ultraviolet light or heat, and voila, they become the cannabinoids we know: THC, CBD and CBC.
CBG interacts with the endocannabinoid system. Instead of modifying CB1 and CB2 like CBD, research has shown that CBG binds primarily with CB2 receptors and in high doses it could block other compounds from binding with CB1 receptors. By blocking CB1 it can help lessen the psychoactive effects of THC. The CB2 receptors help regulate the immune response, reducing inflammation and creating homeostasis. Although little research has been conducted for this cannabinoid, it is showing a wide variety of possible medical benefits. Which include, reduction of intraocular pressure, neuroprotective properties, stimulating bone formation and healing, antibiotic and antibacterial effects, and pain relief.
Studies have been conducted showing the effects of CBG and other cannabinoids on bone marrow cultures. The results showed that they could stimulate bone marrow stem cells indirectly through the CB2 receptor. This suggests that CBG and other cannabinoids, such as CBD and THC may help with the healing of bone fractures by promoting new bone growth and studies to reduce inflammation by activating the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPARy) and inhibiting the release of pro-inflammatory mediators and microglial cells.
In other words it inhibits inflammation in nerve and muscle cells. Researchers have also discovered antibacterial and anti-fungal properties in CBG. Most notably, CBG showed potent activity against Staphylococcus aureus – an antibiotic resistant strain of bacteria. These findings suggest potential for CBG as an antibacterial agent in treating bacterial infections that are non responsive to existing antibiotics.